222 related articles for article (PubMed ID: 19617849)
21. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon.
Ayouba A; Tene G; Cunin P; Foupouapouognigni Y; Menu E; Kfutwah A; Thonnon J; Scarlatti G; Monny-Lobé M; Eteki N; Kouanfack C; Tardy M; Leke R; Nkam M; Nlend AE; Barré-Sinoussi F; Martin PM; Nerrienet E;
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):274-80. PubMed ID: 14600571
[TBL] [Abstract][Full Text] [Related]
22. Maternal HIV-1 DNA load and mother-to-child transmission.
Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
24. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
[TBL] [Abstract][Full Text] [Related]
25. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Foster C; Lyall H; Olmscheid B; Pearce G; Zhang S; Gibb DM
HIV Med; 2009 Aug; 10(7):397-406. PubMed ID: 19459986
[TBL] [Abstract][Full Text] [Related]
26. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
[TBL] [Abstract][Full Text] [Related]
27. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
[TBL] [Abstract][Full Text] [Related]
28. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.
Kilewo C; Karlsson K; Ngarina M; Massawe A; Lyamuya E; Swai A; Lipyoga R; Mhalu F; Biberfeld G;
J Acquir Immune Defic Syndr; 2009 Nov; 52(3):406-16. PubMed ID: 19730269
[TBL] [Abstract][Full Text] [Related]
29. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.
Bajunirwe F; Massaquoi I; Asiimwe S; Kamya MR; Arts EJ; Whalen CC
Afr Health Sci; 2004 Dec; 4(3):146-54. PubMed ID: 15687066
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
McIntyre JA; Hopley M; Moodley D; Eklund M; Gray GE; Hall DB; Robinson P; Mayers D; Martinson NA
PLoS Med; 2009 Oct; 6(10):e1000172. PubMed ID: 19859531
[TBL] [Abstract][Full Text] [Related]
32. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
[TBL] [Abstract][Full Text] [Related]
33. Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.
Chi BH; Wang L; Read JS; Sheriff M; Fiscus S; Brown ER; Taha TE; Valentine M; Goldenberg R
AIDS; 2005 Nov; 19(16):1857-64. PubMed ID: 16227794
[TBL] [Abstract][Full Text] [Related]
34. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
[TBL] [Abstract][Full Text] [Related]
35. Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
Menegotto M; Magdaleno AM; da Silva CLO; Friedrich L; da Silva CH
Am J Perinatol; 2022 Oct; 39(13):1418-1425. PubMed ID: 33477174
[TBL] [Abstract][Full Text] [Related]
36. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.
Hudelson SE; McConnell MS; Bagenda D; Piwowar-Manning E; Parsons TL; Nolan ML; Bakaki PM; Thigpen MC; Mubiru M; Fowler MG; Eshleman SH
AIDS; 2010 Feb; 24(4):557-61. PubMed ID: 20057308
[TBL] [Abstract][Full Text] [Related]
37. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
38. Incidence, prevalence and associated factors of mother-to-child transmission of HIV, among children exposed to maternal HIV, in Belgaum district, Karnataka, India.
Potty RS; Sinha A; Sethumadhavan R; Isac S; Washington R
BMC Public Health; 2019 Apr; 19(1):386. PubMed ID: 30954068
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.
Shapiro RL; Smeaton L; Lockman S; Thior I; Rossenkhan R; Wester C; Stevens L; Moffat C; Arimi P; Ndase P; Asmelash A; Leidner J; Novitsky V; Makhema J; Essex M
J Infect Dis; 2009 Feb; 199(3):414-8. PubMed ID: 19090775
[TBL] [Abstract][Full Text] [Related]
40. Preventing mother to child transmission of HIV: lessons learned from China.
Dong Y; Guo W; Gui X; Liu Y; Yan Y; Feng L; Liang K
BMC Infect Dis; 2020 Oct; 20(1):792. PubMed ID: 33106179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
